Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Cytotoxicity Imaging

July 27, 2010 8:28 am | Product Releases | Comments

Genetix, a leading provider of solutions for imaging and image analysis, announces the availability of an independent, peer-reviewed publication comparing cytotoxicity testing using its CloneSelect Imager system against the conventional, widely-used, colorimetric MTT assay.


Interaction Analysis

July 27, 2010 8:25 am | Drug Discovery & Development | Product Releases | Comments

GE Healthcare has launched the Biacore T200, designed to deliver exceptional sensitivity in the measurement of high-quality kinetic, affinity, concentration, specificity, and thermodynamic interaction data, in real time.


AbD Serotec Signs Deal With University College London

July 27, 2010 8:08 am | News | Comments

AbD Serotec has signed an exclusive license agreement with University College London Business PLC to provide AbD Serotec with access to a potent anti-PTH antibody for commercial use in research and diagnostic applications.


NovImmune to Supply Genentech With Antibodies

July 27, 2010 8:00 am | News | Comments

NovImmune, an antibody-focused research and development biotech company, has entered into an exclusive licensing agreement with Genentech Inc. for a proprietary anti-IL-17 fully human monoclonal antibody, and access to back-up antibodies.


Herpes Protein Allows Cellular Invasion

July 27, 2010 7:54 am | News | Comments

The mechanism by which a herpes virus invades cells has always been a mystery to scientists, but now researchers have revealed that the unusual structure of a key member of the protein complex allows the herpes virus to enter cells.


Key to Intensive Lupus Treatment Discovered

July 27, 2010 7:49 am | News | Comments

Researchers at UT Southwestern Medical Center have uncovered the biological rationale for why large doses of corticosteroids given repeatedly over several weeks may help individuals with lupus.



July 27, 2010 7:41 am | News | Comments

Daiichi Sankyo, Inc. announced that the U.S. Food and Drug Administration approved TRIBENZOR, a new three-in-one combination product taken once-daily for the treatment of hypertension.


Cempra Completes Trial of Potent Antibiotic

July 27, 2010 7:32 am | News | Comments

Cempra Pharmaceuticals announced the successful completion of Phase 1 clinical trials of its oral formulation of CEM-101, which showed good tolerability in those studies.


Study Investigates Importance of Fresh Blood

July 27, 2010 7:16 am | by Lauren Neergaard | News | Comments

Facing surgery? You could receive blood that's been stored for a week, or three weeks, or nearly six - and there's growing concern that people who get the older blood might not fare as well.


Graphene Sheet Electrically Sequences DNA

July 27, 2010 7:11 am | News | Comments

Researchers at the University of Pennsylvania have developed a new, carbon-based nanoscale platform to electrically detect single DNA molecules.


Monash Researchers Turn Fat Into Stem Cells

July 27, 2010 7:05 am | News | Comments

Australian scientists from the Monash Institute of Medical Research have reprogrammed adult mouse fat cells and neural cells to become stem cells that can differentiate into a variety of different cells, pluripotency.


VARI Partners to Develop Phase 1 Cancer Program

July 27, 2010 6:57 am | News | Comments

Cancer patients in West Michigan will soon have the opportunity to access new drugs being developed to fight their disease due to a partnership being formed in Grand Rapids.


Onyx Says Carfilzomib Results Promising

July 27, 2010 6:52 am | News | Comments

Onyx Pharmaceuticals Inc. reported positive clinical trial results for its cancer drug candidate, saying it worked for some multiple myeloma patients who have seen other therapies fail.


Compound Decreases Metabolic Problems From Obesity

July 27, 2010 6:45 am | News | Comments

An experimental compound appears to improve metabolic abnormalities associated with obesity, according to a preliminary study led by researchers at the National Institutes of Health. A report of the study, which was conducted with obese mice, appears online in the Journal of Clinical Investigation.


Merck Partnering With Sinopharm On Vax

July 27, 2010 6:33 am | News | Comments

Merck & Co. said it will team up with Sinopharm, a huge Chinese distributor and maker of pharmaceutical and other health products, to market vaccines and potentially other drugs.



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.